Clinical progression in Parkinson disease and the neurobiology of axons

Cited by (1,001)

Items 601–700 of 1,001

1. Neuroprotective role of traditional Chinese plant extracts on Parkinson's disease; a comprehensive preclinical review
   Rabia Anjum · 2025 · Pharmacological Research - Modern Chinese Medicine
2. Gut-oriented disease modifying therapy for Parkinson's disease
   Chin‐Hsien Lin, Hsin‐Chih Lai, Ming‐Shiang Wu · 2022 · Journal of the Formosan Medical Association
3. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
   Ryoji Goto, Masanori Kurihara, Masashi Kameyama, Hiroki Komatsu, Masashi Higashino, Keiko Hatano, Ryoko Ihara, Mana Higashihara, Yasushi Nishina, Tomoyasu Matsubara et al. · 2023 · Journal of Neural Transmission
4. Induction of axon growth in the adult brain: A new approach to restoration in Parkinson's disease
   Shalini Padmanabhan, Robert E. Burke · 2017 · Movement Disorders
5. KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity
   Luis Arturo Fonseca-Fonseca, Yanier Núñez-Figueredo, Jeney Ramírez-Sánchez, Maylin Wong Guerra, Estael Ochoa, Yamila Verdecia-Reyes, René Delgado, Noelio J. Menezes-Filho, Teresa Cristina Silva Costa, Wagno Alcântara de Santana et al. · 2018 · Neurotoxicity Research
6. Role of rodent models in advancing precision medicine for Parkinson's disease
   Emily Simons, Sheila M. Fleming · 2023 · Handbook of clinical neurology
7. Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma
   Asterios Chrysou, Tuomas Heikka, Sygrid van der Zee, Jeffrey M. Boertien, Nomdo M. Jansonius, Teus van Laar · 2024 · Journal of Parkinson s Disease
8. 18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease
   Joseph R. Winer, Hillary A. Vossler, Christina B. Young, Viktorija Smith, America Romero, Marian Shahid, Carla Abdelnour Ruiz, Edward N. Wilson, David Anders, Aimara Pacheco Morales et al. · 2024 · Brain Communications
9. Neurodegeneration in Parkinson’s disease: are we looking at the right spot?
   Gabriel S. Rocha, Marco Aurélio M. Freire, Daniel Falcão, Tiago F. Outeiro, Rafael Rodrigues Lima, José Ronaldo dos Santos · 2025 · Molecular Brain
10. Enhancing peripheral nerve regeneration in aging: the role of Schwann cells, c-Jun, and emerging therapeutic strategies
    Melod Mehdipour, Viral Thakkar, Stephano J. Chang · 2025 · GeroScience
11. Intranasal delivery of DPSC-derived small extracellular vesicles-encased phloroglucinol attenuates non-motor and motor deficits and promotes neurogenesis in an in vivo rat model of Parkinson’s disease
    Kallolika Mondal, Rituparna Ghanty, Anita Mahadevan, Girish Waghmare, Rashmi Santhoshkumar, Bevinahalli N. Nandeesh, Indrani Datta · 2025 · Stem Cell Research & Therapy
12. Perspective insights and application of exosomes as a novel tool against neurodegenerative disorders: An expository appraisal
    Amey Kadbhane, Monica Patel, Saurabh Srivastava, Pankaj Kumar Singh, Jitender Madan, Shashi Bala Singh, Dharmendra Kumar Khatri · 2021 · Journal of Drug Delivery Science and Technology
13. Parkin Knockdown Modulates Dopamine Release in the Central Complex, but Not the Mushroom Body Heel, of Aging Drosophila
    Eduard Dumitrescu, Jeffrey M. Copeland, B. Jill Venton · 2022 · ACS Chemical Neuroscience
14. Astragaloside IV ameliorates radiation‐induced nerve cell damage by activating the BDNF / TrkB signaling pathway
    Xin Liu, Yanping Ding, Chenxin Jiang, Xin Ma, Yuanyuan Xin, Yingdong Li, Shengxiang Zhang, Baoping Shao · 2023 · Phytotherapy Research
15. Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice
    Alexander Pilski, Steven M. Graves · 2023 · International Journal of Molecular Sciences
16. A neurally plausible schema-theoretic approach to modelling cognitive dysfunction and neurophysiological markers in Parkinson's disease
    Andrea Caso, Richard Cooper · 2020 · Neuropsychologia
17. Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation
    Kentaro Togashi, Masaya Hasegawa, Jun Nagai, Ken Kotaka, Arina Yazawa, Miyuki Takahashi, Daiki Masukawa, Yoshio Goshima, Kenneth Hensley, Toshio Ohshima · 2020 · Journal of the Neurological Sciences
18. Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson’s disease
    Ebenezer O. Farombi, Ifeoluwa Oluleke Awogbindin, Olatunde Owoeye, Victoria O. Abah, Edirin R. Izomoh, Ibukunoluwa O. Ezekiel · 2020 · Metabolic Brain Disease
19. Assessing the Capability of Deep-Learning Models in Parkinson’s Disease Diagnosis
    Christopher West, Sara Soltaninejad, Irene Cheng · 2020 · Lecture notes in computer science
20. Altered sensorimotor fMRI directed connectivity in Parkinson's disease patients
    Gadi Goelman, Rotem Dan, Filip Růžička, Ondřej Bezdíček, Robert Jech · 2020 · European Journal of Neuroscience
21. Striatal Synapse Degeneration and Dysfunction Are Reversed by Reactivation of Wnt Signaling
    Soledad Galli, Stefka H. Stancheva, Tom Dufor, Alasdair J. Gibb, Patricia C. Salinas · 2021 · Frontiers in Synaptic Neuroscience
22. The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
    V. E. Blokhin, Maria A. Shupik, Ulyana Gutner, Ekaterina Pavlova, Аlbert T. Lebedev, Olga Aleksandrovna Maloshitskaya, Vsevolod V. Bogdanov, Sergey Anatolyevich Sokolov, A. V. Alessenko, Michael V. Ugrumov · 2022 · Biomolecules
23. Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson’s disease
    Jae Woo Chung, Christopher A. Knight, Abigail E. Bower, Justin P. Martello, John J. Jeka, Roxana Gabriela Burciu · 2023 · PLoS ONE
24. Impact of age on the rotenone-induced sporadic Parkinson's disease model using Drosophila melanogaster
    Wanrui Li, Xuanyi Pan, Ming Li, Ling Li, Mengmeng Zhang, Ziming liu, Ke Zhang, Jiguang Guo, Hongjie Wang · 2023 · Neuroscience Letters
25. Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling
    Pepin Marshall · 2023 · Cellular and Molecular Neurobiology
26. Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 ( NPTX1 ) as synapto‐axonal target in late‐stage Parkinson's disease
    Carmina Carelia Warth Pérez Arias, Ivan Silbern, Lucas Caldi Gomes, Hannes Wartmann, Vivian Dambeck, Jonas Fanz, Lisa Neuenroth, Mathias Bähr, Tiago F. Outeiro, Stefan Bonn et al. · 2023 · Journal of Neurochemistry
27. Relationship Between Melatonin Receptor Agonists and Parkinson's Disease
    Yoshihiro Noguchi, Rikuto Masuda, Haruka Aizawa, Tomoaki Yoshimura · 2024 · Journal of Pineal Research
28. Frequency and longitudinal course of autonomic reflex testing abnormalities in isolated REM sleep behavior disorder
    Hash Brown Taha, Jennifer Zitser, Mitchell G. Miglis · 2025 · SLEEP
29. A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
    Vignayanandam Ravindernath Muddapu, Karthik Vijayakumar, Keerthiga Ramakrishnan, V. Srinivasa Chakravarthy · 2022 · Frontiers in Neuroscience
30. Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
    Brady S. Mannett, Braden Capt, Krista Pearman, Lori M. Buhlman, John M. VandenBrooks, Gerald B. Call · 2022 · Parkinson s Disease
31. Increased Free Water in the Putamen in Idiopathic REM Sleep Behavior Disorder
    Dongling Zhang, Liche Zhou, Junye Yao, Yuting Shi, Hongjian He, Hongjiang Wei, Qiqi Tong, Jun Liu, Tao Wu · 2023 · Movement Disorders
32. Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity
    Daniel M. Virga, Jessica Capps, Bhupinder P. S. Vohra · 2018 · Neurochemical Research
33. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism
    Temitope Samson Adu, Musa Vuyisile Mabandla · 2019 · Metabolic Brain Disease
34. Assessment of vitamin D and inflammatory markers profile in cardiac tissue on Parkinson disease animal model
    Mariana Bocca Nejm, Marcia Guimarães‐Marques, Leandro Freitas Oliveira, Laís D. Rodrigues, Mônica L. Andersen, Sergio Brasil Tufik, Fernando Fonseca, Efraín Olszewer, Renato Galão Cerquinho Leça, Antonio Carlo G. de Almeida et al. · 2020 · Pharmacological Reports
35. Hippocampal and Reticulo-Thalamic Parvalbumin Interneurons and Synaptic Re-Organization during Sleep Disorders in the Rat Models of Parkinson’s Disease Neuropathology
    Ljiljana T. Radovanovic, Jelena Petrović, Jasna Šaponjić · 2021 · International Journal of Molecular Sciences
36. Oxidative Stress Inhibition Via Apocynin Prevents Medullary Respiratory Neurodegeneration and Respiratory Pattern Dysfunction in a 6-Hydroxydopamine Animal Model of Parkinson’s Disease
    André L F Nascimento, Pamela O S Medeiros, Luiz Fernando A. T. Pedrão, Vitoria Caroline Queiroz, Luiz Marcelo Oliveira, Leonardo Santana Novaes, Ariadiny Lima Caetano, Carolina Demarchi Munhoz, Ana Carolina Thomaz Takakura, Bárbara Falquetto · 2022 · Neuroscience
37. The effect of striatal pre‐enkephalin overexpression in the basal ganglia of the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease
    Stéphanie Bissonnette, Sophie Muratot, Nathalie Vernoux, François Bezeau, Frédéric Calon, Sébastien S. Hébert, Pershia Samadi · 2014 · European Journal of Neuroscience
38. Early bioenergetic and autophagy impairments at the Parkinson’s disease synapse
    G. Aleph Prieto, Carl W. Cotman · 2022 · Brain
39. Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson’s Disease
    Ana Carla L. Nunes, Marta Regina Santos do Carmo, Andrea Behrenswerth, Paula M. Canas, Paula M. Agostinho, Rodrigo Antunes Cunha · 2024 · International Journal of Molecular Sciences
40. In Vivo Study of Moringa oleifera Seed Extracts as Potential Sources of Neuroprotection against Rotenone-Induced Neurotoxicity
    Chand Raza, S MOHSIN, Mehwish Faheem, Uzma Hanif, Hamad Zaid Alkhathlan, Mohammed Rafi Shaik, Hasib Aamir Riaz, Rabia Anjum, Husna Jurrat, Merajuddin Khan · 2024 · Plants
41. Radiomics score derived from T1-w/T2-w ratio image can predict motor symptom progression in Parkinson’s disease
    Takuya Shimozono, Takuro Shiiba, Kazuki Takano · 2024 · European Radiology
42. The Fundamental Neurobiological Mechanism of Oxidative Stress-Related 4E-BP2 Protein Deamidation
    Davis Joseph · 2024 · International Journal of Molecular Sciences
43. Autophagic signatures in peripheral blood mononuclear cells from Parkinson's disease patients
    Myung Shin Lee, Jae Whan Kim, Don Gueu Park, Hansol Heo, Juyeong Kim, Jung Han Yoon, Jaerak Chang · 2024 · Molecules and Cells
44. Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson’s disease
    Myat Noe Han, Madeleine R. Di Natale, Enie Lei, John B. Furness, David Isaac Finkelstein, Marlene M. Hao, Shanti Diwakarla, Rachel Mai McQuade · 2025 · Acta Neuropathologica Communications
45. PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
    Sherilyn Junelle Recinto, Alexandra Kazanova, Lin Liu, Brendan Cordeiro, Shobina Premachandran, Hicham Bessaiah, Alexis Allot, Elia Afanasiev, Sriparna Mukherjee, Jessica Pei et al. · 2025 · npj Parkinson s Disease
46. Nigral volume loss in prodromal, early, and moderate Parkinson’s disease
    Jason A. Langley, Kristy Hwang, Daniel E. Huddleston, Xiaoping Philip Hu, On behalf of the Parkinson’s Progression Marker Initiative · 2025 · npj Parkinson s Disease
47. Towards scalable screening for the early detection of Parkinson’s disease: validation of an iPad-based eye movement assessment system against a clinical-grade eye tracker
    Jamie Koerner, Erin Zou, Jessica A. Karl, Cynthia Poon, Leo Verhagen Metman, C.G. Sodini, Vivienne Sze, Fabian J. David, Thomas Heldt · 2025 · npj Parkinson s Disease
48. Synuclein and Parkinson’s Disease: An Update
    K. A. Jellinger · 2013 · Royal Society of Chemistry eBooks
49. Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
    Eun Hye Jeong, Mun Kyung Sunwoo, Jae Yong Lee, Sun-Ku Han, Sung Wook Hyung, Yoo Sung Song · 2022 · Frontiers in Neurology
50. Striatal Subregion-selective Dysregulated Dopamine Receptor-mediated Intracellular Signaling in a Model of DOPA-responsive Dystonia
    Kaitlyn M. Roman, Maria A. Briscione, Yuping Donsante, Jordan Ingram, Xueliang Fan, Douglas Bernhard, Simone A. Campbell, Anthony M. Downs, David A. Gutman, Tejas Arvind Sardar et al. · 2023 · Neuroscience
51. Comparative analysis of machine learning techniques for Parkinson’s detection: A review
    Ketna Khanna, Sapna Gambhir, Mohit Gambhir · 2023 · Multimedia Tools and Applications
52. Activation and polarization of striatal microglia and astrocytes are involved in bradykinesia and allodynia in early-stage parkinsonian mice
    Xue Zhang, Zi-Lin Shen, Ya-Wei Ji, Cui Yin, Cheng Xiao, Chunyi Zhou · 2023 · Fundamental Research
53. Combining fibril‐induced alpha‐synuclein aggregation and 6‐hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration
    Aastha Singh, Anne E. Panhelainen, Saku Reunanen, Kelvin C. Luk, Merja H. Voutilainen · 2023 · European Journal of Neuroscience
54. Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease.
    M. T. Mazzocco, Marcello Serra, Marco Maspero, A. Coliva, Luca Presotto, Maria Antonietta Casu, Micaela Morelli, R. Moresco, S. Belloli, A. Pinna · 2024 · Experimental Neurology
55. Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease
    Pathik Parekh, Marcello Serra, Mohamad Allaw, Matteo Perra, Annalisa Pinna, Maria Manconi, Micaela Morelli · 2024 · Experimental Neurology
56. Cell Therapies for Parkinson's Disease
    Stefan Irion · 2019 · Clinical and Translational Science
57. Skin Fibroblasts as the Object for Clinical Diagnosis of Parkinson’s Disease in Persons of Different Ages
    V. A. Zuev, Anastasiia Dyatlova, Natalia Sergeevna Linkova, И. М. Кветной, Belushkina Nn, V. A. Pal’tsev · 2019 · Bulletin of Experimental Biology and Medicine
58. Can sex influence the neurocognition of language? Evidence from Parkinson's disease
    Jana Reifegerste, Ivy V. Estabrooke, Lauren E. Russell, João Veríssimo, Karim Johari, Barbara Wilmarth, Fernando Pagán, Charbel Moussa, Michael T. Ullman · 2020 · Neuropsychologia
59. Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
    Dhanya Vijayakumar, Joseph J. Jankovic · 2022 · CNS Drugs
60. Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation
    Vibeke Devold Valderhaug, Ola Huse Ramstad, Rosanne van de Wijdeven, Kristine Heiney, Stefano Nichele, Axel Sandvig, Ioanna Sandvig · 2024 · Frontiers in Cellular Neuroscience
61. The Leukocentric Theory of Neurological Disorder: A Manifesto
    Robert F. Fern · 2017 · Neurochemical Research
62. Systematic review of the pharmacoeconomics of Parkinson disease medications
    Alexander S. Wang, Steven A. Gunzler · 2019 · Expert Opinion on Pharmacotherapy
63. REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    Abdallah Ahnaou, Wilhelmus H. I. M. Drinkenburg · 2022 · Neuroscience & Biobehavioral Reviews
64. Occipital hypoperfusion and motor reserve in Parkinson’s disease: an early-phase 18F-FP-CIT PET study
    Yeo Jun Yoon, Su Hong Kim, Seong Ho Jeong, Chan Wook Park, Hye Sun Lee, Phil Hyu Lee, Yun Joong Kim, Young H. Sohn, Yong Jeong, Seok Jong Chung · 2024 · npj Parkinson s Disease
65. Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network
    Eesha Bharti, Adele L. DeNicola, Ying Yu, Ajay Kumar Verma, David D. Schneck, Biswaranjan Mohanty, Mark Joseph A. Fiecas, Hongyu Yao, Jing Wang, Luke A. Johnson et al. · 2025 · Neurobiology of Disease
66. Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson's Disease: A Randomized, Placebo‐Controlled, Double‐Blinded Study
    Monika Figura, Łukasz Milanowski, Julia Maya Nowak, Aleksandra Antoniak, Mateusz Kopczyński, Weronika Zając, Karol Sadowski, Łukasz Hołubiuk, Weronika Walęcik-Kot, Stanisław Szlufik et al. · 2026 · Annals of Neurology
67. Aging of the Nigrostriatal Tract in the Human Brain: A Diffusion Tensor Imaging Study
    Jeong-Pyo Seo, Dong-Kyun Koo · 2021 · Medicina
68. Reserpine-Induced Progressive Parkinsonism in Mice Predisposed and Non-Predisposed to Depressive-Like Behavior
    Manuela B. L. Soares, Leonardo B. Lopes-Silva, Marcela S. Becegato, Vinícius S. Bioni, Alvaro C. Lima, Gabriela M. Ferreira, Ywlliane da Silva Rodrigues Meurer, Regina H. Silva · 2021 · Journal of Behavioral and Brain Science
69. Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms
    Emma Brolin, Martin Ingelsson, Joakim J. E. Bergström, Anna Erlandsson · 2023 · Cellular and Molecular Neurobiology
70. A Machine Learning Approach for Early Identification of Prodromal Parkinson’s Disease
    Anisha Vaish · 2024 · Cureus
71. Behavior, PET and histology in novel regimen of MPTP marmoset model of Parkinson’s disease for long-term stem cell therapy
    Jun-Won Yun, Jae-Bum Ahn, Euna Kwon, Jae Hun Ahn, Hyung Woo Park, Hwon Heo, Jin‐Sung Park, Hyeon-Jin Kim, Sun Ha Paek, Byeong-Cheol Kang · 2015 · Tissue Engineering and Regenerative Medicine
72. Serotonin in Parkinson's disease
    Z. Kohl, J. Winkler · 2020 · Handbook of Behavioral Neuroscience
73. HFE H63D Limits Nigral Vulnerability to Paraquat in Agricultural Workers
    Ernest W. Wang, Max L Trojano, Mechelle M. Lewis, Guangwei Du, Hairong Chen, Gregory L. Brown, Leslie C. Jellen, Insung Y. Song, Elizabeth B. Neely, Lan Kong et al. · 2021 · Toxicological Sciences
74. Deep brain stimulation-induced neuroprotection: A critical appraisal
    Keyoumars Ashkan, Maria Alexandra Velicu, Luciano Lopes Furlanetti · 2022 · European Journal of Paediatric Neurology
75. Parkinson's disease fluid biomarkers for differential diagnosis of atypical parkinsonian syndromes
    Jun Yang, Ayotimofe Idowu, Liana S. Rosenthal, Xiaobo Mao · 2022 · Clinical and Translational Discovery
76. Dopamine agonists in treatment of Parkinson's disease: an overview
    Dan Luo, Maarten E. A. Reith, Aloke K. Dutta · 2020 · Elsevier eBooks
77. Etiology and pathogenesis of Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
78. Identification of Blood-based Biomarkers for Early Stage Parkinson’s Disease
    Andrew Gao · 2020 · medRxiv
79. The Mitochondrial Connection in Parkinson's Disease
    Eric A. Schon, Diana Matheoud, Serge Przedborski · 2025 · Cold Spring Harbor Perspectives in Medicine
80. Roles of Microglia in Synaptogenesis, Synaptic Pruning, and Synaptic Plasticity in Physiological Conditions and Central Nervous System Disorders
    Xie, Meizhen, Wang, Tian, Feng, Jiachun, Ma, Di, Feng, Liangshu, Hao, Yulei · 2025 · Current Neuropharmacology
81. Human iPSC Models in Drug Discovery: Opportunities and Challenges
    Silva, M.C., Cross, A., Brandon, N.J., Haggarty, S.J. · 2017 · Comprehensive Medicinal Chemistry III
82. A bibliometric analysis of speech and language impairments in Parkinson’s disease based on Web of Science
    Xueyao Pan, Bingqian Liang, Ting Cao · 2024 · Frontiers in Psychology
83. Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson’s Disease
    Samantha Edwards, Frances Corrigan, Lyndsey E. Collins‐Praino · 2025 · Molecular Neurobiology
84. Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei
    Vasileios Theologidis, Sara Almeida Ferreira, Nanna Møller Jensen, Diana Gomes Moreira, Ole Andreas Ahlgreen, Mads W. Hansen, Emilie D. Rosenberg, Mette Richner, Islam Mustafa Galal Faress, Hjalte Gram et al. · 2025 · Acta Neuropathologica Communications
85. Midbrain and pallidal iron changes identify patients with REM sleep behaviour disorder and Parkinson’s disease
    Erind Alushaj, Alan B Kuurstra, Ravi S. Menon, Hooman Ganjavi, Anisa Morava, Manas Sharma, Alia Kashgari, Jennifer Barr, William Michael Reisman, ALI RAZA KHAN et al. · 2025 · npj Parkinson s Disease
86. Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches
    Sean A. Freeman, Ikram Ayoub, Yves A Dauvilliers, Roland Liblau · 2025 · Seminars in Immunology
87. Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson’s Disease
    Bárbara Carneiro-Pereira, Filipa Ferreira-Antunes, Jonas Campos, António José Salgado, Belém Sampaio‐Marques · 2025 · Molecules
88. Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C60) and Fullerenol (C60(OH)24)
    Tatyana V. Strekalova, Alisa Burova, Горлова Анна Вячеславовна, Kirill Chaprov, Anastasia Khizeva, Joana Esteves Coelho, Evgeniy P. Svirin, Polina V. Novikova, Lia Ohanyan, Johannes de Munter et al. · 2025 · Biomedicines
89. Phosphorylation of α-Synuclein Fibrils at S129 Changes DNAJB1 Binding as Probed by Solid-State NMR
    Sayuri Pacheco, Dhanya S. Reselammal, Shanlong Li, Zhang Qing-ya, Gauri Velloor, Jianhan Chen, Ansgar B. Siemer · 2025 · JACS Au
90. Parkinson’s Disease: From Gene–Environment Risk to Precision Therapy
    Óscar Arias-Carrión · 2026 · Medical Sciences
91. Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit
    Jason A. Langley, Kristy Hwang, Xiaoping Philip Hu, Daniel E. Huddleston · 2022 · Frontiers in Neuroscience
92. Regional serotonin terminal density in aging human brain: A [11C]DASB PET study
    Prabesh Kanel, Robert A. Koeppe, Vikas Kotagal, Stiven Roytman, Martijn L.T.M. Müller, Nicolaas Ida Bohnen, Roger L. Albin · 2023 · Aging Brain
93. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson’s Disease
    Jennifer Sally Samson, Anuradha Ramesh, Venkatachalam Deepa Parvathi · 2024 · Neuroscience
94. AdipoRon improves mitochondrial homeostasis and protects dopaminergic neurons through activation of the AMPK signaling pathway in the 6-OHDA-lesioned rats
    Seyed Zanyar Athari, ‬Rana Keyhanmanesh, Fereshteh Farajdokht, Mohammad Karimipour, Negin Azizifar, Soraya Alimohammadi, Gisou Mohaddes · 2024 · European Journal of Pharmacology
95. The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation
    Davis Joseph · 2025 · International Journal of Molecular Sciences
96. Human umbilical cord-derived mesenchymal stromal cells ameliorated motor defects of 6-OHDA-induced rat model of Parkinson's disease
    Fabin Han, Chao Chen, Wei Wang, Hao Song, Sen Li, Jing Duan, Xianjie Lu, Shichao Wu, Nan Zhang, Qingfa Chen et al. · 2018 · Oncotarget
97. APOE ε4 Allele-associated Alzheimer's disease risk is consistent with increased lifetime exposure to a neurotoxic process
    Carr J. Smith, John Wesson Ashford · 2017 · Journal of Systems and Integrative Neuroscience
98. Advances in PET Methodology
    Vesna Sossi · 2018 · International review of neurobiology
99. A Microfluidic System for Investigating Anticipatory Medication Effects on Dopamine Homeostasis in Dopaminergic Cells
    Samhwan Kim, Seongtak Kang, Jiyun Choe, Cheil Moon, Hongsoo Choi, Jinyoung Kim, Ji-Woong Choi · 2023 · Analytical Chemistry
100. 6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons
     Nilufar Ali, Mukta S. Sane, Huiyuan Tang, Jadon Compher, Quinlan McLaughlin, Christopher D. Jones, Shivani Kaushal Maffi · 2023 · Neurochemistry International